Here are five things to know:
1. The total transaction was valued at $15.5 million.
2. Braun Stacey Associates owned about 0.41 percent of AmSurg at the end of the most recent reporting period.
3. AmSurg has a 12-month low of $49.25 and a 12-month high of $87.42.
4. The company has a 50-day moving average of $81.15 and a 200-day moving average of $76.96.
5. The firm has a market cap of $3.91 billion.
More articles on ASC issues:
40 statistics on ASC case mix — Orthopedics, GI, pain & more
Bariatric surgery provides low risk for heart attacks and type 2 diabetes — 5 key findings
26 great books for ASC leaders — 2016 reading list
